Dr. Rennebohm is a pediatrician and pediatric rheumatologist. He is currently largely retired. In 2018 he officially retired from the pediatric rheumatology department at Cleveland Clinic, where he was also the Director of the International Susac Syndrome Consultation Service. Prior to that, he was at Alberta Children’s Hospital in Calgary, Canada, where he was Clinical Professor of Pediatrics and Pediatric Rheumatology; before that he was at Nationwide Children’s Hospital and Ohio State University in Columbus, Ohio, where he was Associate Professor of Pediatrics and Chief of Pediatric Rheumatology for 20 years; and before that he was a pediatric rheumatologist at Cincinnati Children’s Hospital.
Very interesting. Thank you for the interview. Dr Robert Rennebohm, and Dr Philip McMillan will have to make another interview in the future because there are many, still unresolved questions regarding auto-immunity in pediatric patients with Covid-19. There are growing interest around a world about multisystem inflammatory syndrome in children several days to weeks after resolution of the initial infection. One hypothesis is superantigenic characteristics of SARS-CoV-2 with regard to S protein binding to TCRs and hyperactivating T cell responses. The second hypothesis is zonulin-dependent loss of gut mucosal barrier that increases in gut permeability allowing SARS-CoV-2 antigens, including the superantigen-like motif of the spike protein, to traffic across mucosal barriers and into the bloodstream and cause massive inflammation and autoimmune responses. And this has been observed in children only.
Thank you so much for this presentation. Love how God is raising up just the right people for such a time as this. Such a labor of love for humanity... for our children and grandchildren. Thank you Dr. Rennebohm for writing it all down! I bet Dr. Vanden Bossche is blessed to have soul mate scientist who shares similar ideas. God's blessings to you all for such great work!
Very interesting. Thank you for the interview. Dr Robert Rennebohm, and Dr Philip McMillan will have to make another interview in the future because there are many, still unresolved questions regarding auto-immunity in pediatric patients with Covid-19. There are growing interest around a world about multisystem inflammatory syndrome in children several days to weeks after resolution of the initial infection. One hypothesis is superantigenic characteristics of SARS-CoV-2 with regard to S protein binding to TCRs and hyperactivating T cell responses. The second hypothesis is zonulin-dependent loss of gut mucosal barrier that increases in gut permeability allowing SARS-CoV-2 antigens, including the superantigen-like motif of the spike protein, to traffic across mucosal barriers and into the bloodstream and cause massive inflammation and autoimmune responses. And this has been observed in children only.
Looking forward to see your joint efforts.
So awesome 👏 appreciate your courage 💪
Clear & helpful advice, we need this.
The New Rules of Medicine
https://stevekirsch.substack.com/p/the-new-rules-of-medicine-bf7?s=r
Thank you so much for this presentation. Love how God is raising up just the right people for such a time as this. Such a labor of love for humanity... for our children and grandchildren. Thank you Dr. Rennebohm for writing it all down! I bet Dr. Vanden Bossche is blessed to have soul mate scientist who shares similar ideas. God's blessings to you all for such great work!